Literature DB >> 29222302

Pain-measurement tools in sickle cell disease: where are we now?

Deepika S Darbari1,2, Amanda M Brandow3,4.   

Abstract

Pain is a complex multidimensional experience and the most common morbidity in patients with sickle cell disease (SCD). Tools to assess pain can be of use not only to guide pain treatment but also to provide insight into underlying pain neurobiology. Mechanisms of pain in SCD are multifactorial and are not completely elucidated. Although vaso-occlusion of microcirculation by sickled red cells is believed to be the underlying mechanism of acute vaso-occlusive pain, mechanisms for chronic pain and the transition from acute to chronic pain are under investigation. A number of modalities can be used in clinical practice and/or research to capture various dimensions of pain. Selection of a pain-assessment tool should be directed by the purpose of the assessment. Pain-assessment tools, many of which are currently in the early stages of validation, are discussed here. Development and validation of these multimodal tools is crucial for developing improved understanding of SCD pain and its management.
© 2016 by The American Society of Hematology. All rights reserved.

Entities:  

Mesh:

Year:  2017        PMID: 29222302      PMCID: PMC6142608          DOI: 10.1182/asheducation-2017.1.534

Source DB:  PubMed          Journal:  Hematology Am Soc Hematol Educ Program        ISSN: 1520-4383


  62 in total

1.  Development, Content Validity, and User Review of a Web-based Multidimensional Pain Diary for Adolescent and Young Adults With Sickle Cell Disease.

Authors:  Nitya Bakshi; Jennifer N Stinson; Diana Ross; Ines Lukombo; Nonita Mittal; Saumya V Joshi; Inna Belfer; Lakshmanan Krishnamurti
Journal:  Clin J Pain       Date:  2015-06       Impact factor: 3.442

Review 2.  Early insights into the neurobiology of pain in sickle cell disease: A systematic review of the literature.

Authors:  Amanda M Brandow; Rebecca A Farley; Julie A Panepinto
Journal:  Pediatr Blood Cancer       Date:  2015-05-13       Impact factor: 3.167

3.  Chronic Opioid Therapy and Central Sensitization in Sickle Cell Disease.

Authors:  C Patrick Carroll; Sophie Lanzkron; Carlton Haywood; Kasey Kiley; Megan Pejsa; Gyasi Moscou-Jackson; Jennifer A Haythornthwaite; Claudia M Campbell
Journal:  Am J Prev Med       Date:  2016-07       Impact factor: 5.043

4.  Health-related quality of life in adults with sickle cell disease (SCD): a report from the comprehensive sickle cell centers clinical trial consortium.

Authors:  Carlton Dampier; Petra LeBeau; Seungshin Rhee; Susan Lieff; Karen Kesler; Samir Ballas; Zora Rogers; Winfred Wang
Journal:  Am J Hematol       Date:  2011-02       Impact factor: 10.047

5.  Regional cerebral activation in irritable bowel syndrome and control subjects with painful and nonpainful rectal distention.

Authors:  H Mertz; V Morgan; G Tanner; D Pickens; R Price; Y Shyr; R Kessler
Journal:  Gastroenterology       Date:  2000-05       Impact factor: 22.682

6.  Disease-Related, Nondisease-Related, and Situational Catastrophizing in Sickle Cell Disease and Its Relationship With Pain.

Authors:  Vani A Mathur; Kasey B Kiley; C Patrick Carroll; Robert R Edwards; Sophie Lanzkron; Jennifer A Haythornthwaite; Claudia M Campbell
Journal:  J Pain       Date:  2016-08-20       Impact factor: 5.820

7.  Mechanism-driven phase I translational study of trifluoperazine in adults with sickle cell disease.

Authors:  Robert E Molokie; Diana J Wilkie; Harriett Wittert; Marie L Suarez; Yingwei Yao; Zhongsheng Zhao; Ying He; Zaijie J Wang
Journal:  Eur J Pharmacol       Date:  2013-11-07       Impact factor: 4.432

Review 8.  Measures of adult pain: Visual Analog Scale for Pain (VAS Pain), Numeric Rating Scale for Pain (NRS Pain), McGill Pain Questionnaire (MPQ), Short-Form McGill Pain Questionnaire (SF-MPQ), Chronic Pain Grade Scale (CPGS), Short Form-36 Bodily Pain Scale (SF-36 BPS), and Measure of Intermittent and Constant Osteoarthritis Pain (ICOAP).

Authors:  Gillian A Hawker; Samra Mian; Tetyana Kendzerska; Melissa French
Journal:  Arthritis Care Res (Hoboken)       Date:  2011-11       Impact factor: 4.794

9.  Impact of emergency department care on outcomes of acute pain events in children with sickle cell disease.

Authors:  Amanda M Brandow; Mark Nimmer; Timothy Simmons; T Charles Casper; Lawrence J Cook; Corrie E Chumpitazi; J Paul Scott; Julie A Panepinto; David C Brousseau
Journal:  Am J Hematol       Date:  2016-09-03       Impact factor: 10.047

10.  Evoked Pressure Pain Sensitivity Is Associated with Differential Analgesic Response to Verum and Sham Acupuncture in Fibromyalgia.

Authors:  Noah A Zucker; Alex Tsodikov; Scott D Mist; Stephen Cina; Vitaly Napadow; Richard E Harris
Journal:  Pain Med       Date:  2017-08-01       Impact factor: 3.750

View more
  5 in total

1.  Prevalence of neuropathic pain in adolescents with sickle cell disease: A single-center experience.

Authors:  Melissa Cregan; Latika Puri; Guolian Kang; Doralina Anghelescu
Journal:  Pediatr Blood Cancer       Date:  2022-02-11       Impact factor: 3.167

Review 2.  A Comprehensive Review of the Treatment and Management of Pain in Sickle Cell Disease.

Authors:  Jacob Fiocchi; Ivan Urits; Vwaire Orhurhu; Mariam Salisu Orhurhu; Stephen Giacomazzi; Briggs Hoyt; Alan D Kaye; Rachel J Kaye; Omar Viswanath
Journal:  Curr Pain Headache Rep       Date:  2020-03-21

3.  Assessment of health-related quality of life among adults hospitalized with sickle cell disease vaso-occlusive crisis.

Authors:  Kimberly S Esham; Angie Mae Rodday; Hedy P Smith; Farzad Noubary; Ruth Ann Weidner; Rachel J Buchsbaum; Susan K Parsons
Journal:  Blood Adv       Date:  2020-01-14

4.  Emergency Department Provider Survey Regarding Acute Sickle Cell Pain Management.

Authors:  Olufunke Y Martin; Sean M Thompson; Aaron E Carroll; Seethal A Jacob
Journal:  J Pediatr Hematol Oncol       Date:  2020-08       Impact factor: 1.170

5.  The eEgg: Evaluation of a New Device to Measure Pain.

Authors:  Dshamilja M Böing-Meßing; Fabian Tomschi; Thomas Cegla; Thomas Hilberg
Journal:  Front Physiol       Date:  2022-03-28       Impact factor: 4.566

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.